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ABSTRACT – Background and Objectives: It is well-established that psychological inter-
ventions are effective in the treatment of depression. However, it is not yet clear what the
optima format is in which psychological treatments should be delivered. Although several
studies have examined whether individual and group treatments are equally effective in
the treatment of depression, no comprehensive meta-analysis has examined this.
Methods: We searched major bibliographical databased and conducted a meta-analysis
of 15 studies in which individual and group therapies were compared directly to each other.
Results: The mean effect size indicating the difference between individual and group ther-
apies in depressive symptomatology at post-test was 0.20 (95% CI: [0.05 0.35]; p < 0.01), in
favor of individual therapies, with a lower drop-out rate in individual interventions (OR =
0.56; 95% CI: [0.37, 0.86]; p < 0.01). At follow-up no significant differences were found.
Conclusions: Although individual therapy seems to be somewhat more effective than
group therapy at the short term, it is not clear whether this is relevant from a clinical point
of view. Because of the small number of studies and the limited quality, more research is
needed to examine whether the difference between individual and group treatment is clin-
ically relevant.
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Introduction
It is well-established that psychological
interventions are effective in the treatment
of depression, and this is true for a broad
spectrum of treatments including cognitive
behavior therapy1,2, behavioral activation
treatments3, marital therapy4, problem-
solving treatments5, and interpersonal psy-
chotherapy2. These interventions are not
only effective in adults with depression, but
also in older adults6, in women with post-
partum depression,7 and in patients with
both depression and general medical disor-
ders, including multiple sclerosis8, stroke
patients9, and cancer patients10. A large num-
ber of studies has also shown that psycho-
logical treatments of depression in children
and adolescents are effective, but with
smaller effect sizes than in adults11. 
Most research in this area has focused on
the individual treatment of depression,
although the number of studies examining
group interventions is also substantial12.
Whether individual and group treatments of
depression are equally effective, however,
has not yet been established. Some studies
have found individual treatment to be more
effective than group treatment13,14, while
others did not find this15-17. One problem for
studies examining the differences between
individual and group treatments is that these
differences are probably small. Therefore
these studies need very large sample sizes to
be able to find these small differences. 
Meta-analyses have the advantage that they
can integrate the results of individual studies.
Therefore they can detect small differences
better. In the past few years, the differences
between individual and group therapies have
been examined in meta-analytic research, but
without clear outcomes. In one meta-analy-
sis12, the effects of group interventions for
depression were examined. Although one of
the analyses in this study focused on the dif-
ference between group and individual inter-
ventions, it suffered from several limita-
tions. Not all studies in this area were
included (9 studies, compared to the 15 we
identified, see below), no test of homogene-
ity of the sample was conducted, and no
analysis of subgroups, follow-up measures,
or drop-out rates were conducted. However,
this study resulted in some indications that
individual and group interventions did not
differ from each other significantly. One
other meta-analysis2 focused only on brief
interventions, did not include all relevant stud-
ies either (8 of the 15 studies we identified),
and did not conduct subgroup analyses. This
study did find indications that individual ther-
apies are somewhat more effective than group
interventions in the treatment of depression.
The question whether individual and
group treatments are equally effective is
important for several reasons. First, it is
important from the perspective of cost-effec-
tiveness. If group interventions are as effec-
tive as individual therapies, this could reduce
the costs of treatment considerably, because
the costs of group therapy are considerably
lower than the costs of individual therapy18. 
The question whether individual and
group treatments are equally effective is also
important from a clinical and scientific per-
spective. When these treatments are indeed
equally effective, this suggests that the pres-
ence of other patients during the treatment
does not interfere with the treatment of the
individual patient. On the other hand, it may
also be possible that the treatments result in
comparable effects but through different
mechanisms. For example, in individual
treatment the relationship between patient
and therapist may be stronger, while in group
therapy other mechanisms are more impor-
tant, such as cohesion and social support19. 
If individual and group treatments are not
equally effective, this could suggest that one
of the formats is not as good as the other one
in helping the patient to learn the techniques
that are helpful in reducing depression. Or it
could be possible that group processes inter-
fere with the therapeutic process. 
But before these questions can be answered
we first have to know whether group and
individual treatments are indeed equally
effective. Because no clear conclusions could
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be drawn from earlier research, and because
of the importance of the question whether
both formats are equally effective, we decided
to conduct a new meta-analysis. 
Method
Identification and selection of
studies
Studies were traced by means of several
methods. First, we used a large database of stud-
ies on the psychological treatment of depression
in general, which has been described in detail
elsewhere3,5,6,20. This database was developed
through a comprehensive literature search
(from 1966 to May 2007) in which we exam-
ined 5,178 abstracts in Pubmed (1,224
abstracts), Psycinfo (1,336), Embase (1118)
and the Cochrane Central Register of Con-
trolled Trials (1,500). We identified these
abstracts by combining terms indicative of psy-
chological treatment (psychotherapy, psycho-
logical treatment, cognitive therapy, behavior
therapy, interpersonal therapy, reminiscence,
life review) and depression (both MeSH-terms
and text words). For this database, we also col-
lected the primary studies from 22 meta-
analyses of psychological treatment of depres-
sion21. For the current study, we examined the
abstracts of these 777 studies, and selected the
ones which included both an individual and a
group treatment of depression. 
Second, we conducted additional search-
es in computerized literature databases in
which we combined search terms indicative
of individual and group therapy (individual
OR group), in combination with depression
(text and key words) and controlled studies
(both text and key words; randomized OR
randomized OR clinical OR trial OR exper-
imental). For these additional searches we
examined a total of 1,137 abstracts from
Embase (168 abstracts), the Cochrane data-
base (124), Pubmed (293), Psychinfo (364),
and Digital Dissertations (188).
In addition, we examined the references of
earlier meta-analyses2,12, and we reviewed
the reference lists of retrieved papers. We
also contacted the authors of studies that
met inclusion criteria and asked whether
they knew of any other (published and
unpublished) studies in the field. 
We included studies in which1 the effects
of a group treatment2 were compared to an
individual treatment3 in adults4 with a
depressive disorder or an elevated level of
depressive symptomatology5, in a random-
ized trial. No language restrictions were
applied. 
Quality assessment
We assessed the validity of included studies
using four basic criteria, as suggested in the
Cochrane Handbook22: allocation to condi-
tions is done by an independent (third) party;
adequacy of random allocation concealment to
respondents; blinding of assessors of out-
comes; and completeness of follow-up data. 
Meta-analysis
We calculated effect sizes (d) by subtract-
ing (at post-test) the average score of the indi-
vidual treatment condition (Mi) from the aver-
age score of the group treatment condition
(Mg) and dividing the result by the average of
the standard deviations of the experimental
and control group (SDig). An effect size of 0.5
thus indicates that the mean of the experimen-
tal group is half a standard deviation larger
than the mean of the control group. Effect
sizes of .56 to 1.2 can be assumed to be large,
while effect sizes of 0.33 to 0.55 are moder-
ate, and effect sizes of 0 to 0.32 are small23. 
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In the calculations of effect sizes we only
used those instruments that explicitly mea-
sure depression (Table I). If more than one
depression measure was used, the mean of the
effect sizes was calculated, so that each study
(or contrast group) only had one effect size. 
To calculate pooled mean effect sizes, we
used the computer program Comprehensive
Meta-analysis (version 2.2.021), developed
for support in meta-analysis. As we expected
considerable heterogeneity, we decided to
calculate mean effect sizes with the random
effects model. In the random effects model it
is assumed that the included studies are
drawn from ‘populations’ of studies that dif-
fer from each other systematically. In this
model, the effect sizes resulting from includ-
ed studies differ because of the random error
within studies, but also because of true varia-
tion in effect size from one study to the next.
In our analyses, we have tested whether
there are genuine differences underlying the
results of the studies (heterogeneity), or
whether the variation in findings is compati-
ble with chance alone (homogeneity)24. As
indicator of homogeneity, we calculated the
Q-statistic. A significant Q rejects the null-
hypothesis of homogeneity and indicates that
the variability among the effect sizes is
greater than what is likely to have resulted
from subject-level sampling error alone. We
also calculated the I2-statistic which is an
indicator of heterogeneity in percentages as
well. A value of 0% indicates no observed
heterogeneity, and larger values show increas-
ing heterogeneity, with 25% as low, 50% as
moderate, and 75% as high heterogeneity24. 
Subgroup analyses and metaregression
analyses were conducted according to the
procedures as implemented in Comprehen-
sive Meta-analysis version 2.2.021. In the
subgroup analyses, we used the mixed
effects analyses model, in which the studies
in the subgroups were pooled with the ran-
dom effects model; and we used the fixed
effects model to test whether the difference
between the subgroups was significant. 
We also calculated ‘Orwin’s fail safe N’.
This number indicates how many studies
with an effect size of zero should be found
in order to reduce the effect size found to a
smaller value (for example 0.20). A larger N
indicates that the effect size found can be
further generalized.
Finally, we examined whether the drop-
out from the interventions differed in the
individual interventions compared to the
group interventions. Because drop-out is a
dichotomous outcome, we calculated the
odds ratio (OR) of drop-out from the inter-
ventions (in stead of a standardized effect
size). Again, we conducted all meta-analyses
with the random effects model, using the
Comprehensive Meta-analysis (version 2.2.021)
computer program, and we calculated the 
Q-statistic and the I2-statistic to estimate het-
erogeneity between study outcomes.
Results
Description of studies
Fifteen studies, with a total of 673 partici-
pants (276 in the individual treatment condi-
tions, and 397 in the group treatment condi-
tions) met the inclusion criteria and were
included in the current study13-17,25-33. The
selected characteristics of the included studies
are described in Table I. In the fifteen studies,
nineteen comparisons between group and
individual treatments could be made, because
in four studies two group treatments could be
compared to an individual treatment.
One study28 was very similar to another
study29, albeit not in all details, and although
42 PIM CUIJPERS ET AL.
one author was involved in both studies, no
reference was made in the later study to the
earlier study. It was possible that the data
from these two papers were based on the
same research. We tried to contact the
authors of these papers and tried to get an
answer to the question whether these studies
were the same. Unfortunately, the authors
did not respond. Therefore, we conducted
the meta-analyses (see below) both with and
without the earlier study. But because the
results were very similar (see below), we
considered them as two separate studies.
In six studies, participants were recruited
from the community, while in the other stud-
ies participants were recruited from clinical
settings (6 studies), or through systematic
screening (2 studies). One study did not
report the recruitment method. Eleven stud-
ies were focused on adults, while two studies
focused on specific populations (women with
postpartum depression, prison inmates, and
multiple sclerosis patients). In twelve studies,
the participants had to meet diagnostic crite-
ria for depressive disorder as established with
a diagnostic interview. The remaining three
studies included participants who scored
high on a self-rating depression scale. All
studies used the BDI as an outcome measure. 
In thirteen of the nineteen comparisons,
the intervention in the individual and group
interventions were equivalent, while in the
other six comparisons different types of
interventions were used. We considered the
individual and group intervention as equiva-
lent, when the type of treatment and treat-
ment manual were the same (cognitive-
behavior therapy, counseling, interpersonal
therapy), and when the number of sessions
and the length of the sessions was the same
in the group and individual format. In eleven
of the thirteen comparisons in which an
equivalent intervention was used, cognitive
behavioral interventions were administered.
The number of sessions in the individual and
group interventions varied between six and
twenty. Eleven studies were conducted in the
United States, three in the United Kingdom,
and one in Australia.
Quality of included studies
The quality of studies varied. In none of the
studies it was reported that allocation to condi-
tions was conducted by an independent party.
Concealment of random allocation to respon-
dents was not possible or not reported in any of
the studies, while blinding of assessors was
reported in five studies. Drop-out numbers
ranged from 0 to 42.6%. In four studies, inten-
tion-to-treat analyses were conducted. 
Because the number of studies was small
and the quality of included studies was low,
we have to conclude that a meta-analyses of
the available studies can not give a definite
answer to the question whether or not indi-
vidual and group interventions are equally
effective in the treatment of depression. We
doubted whether we should conduct a meta-
analysis or not, given the small number and
quality of studies. We decided, however, to
conduct a meta-analysis, in order to formu-
late hypotheses for future research.
Differences between individual
and group therapies at post-test
The mean effect size indicating the differ-
ence between individual and group therapies
in depressive symptomatology at post-test
was 0.20 (95% CI: [0.05 0.35]; p<0.01).
This indicates that individual therapy is sig-
nificantly more effective than group therapy,
although the effect size indicates a small dif-
ference. Heterogeneity, as indicated with I2
was zero. The results of these meta-analyses
are summarized in Table II and Figure 1. 
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Table II
Meta-analyses of studies comparing the effects of individual psychological treatments to group treatments
for depression: Overall results and subgroup analyses
Study N
comp d 95% CI Z Q a) I2 (%) p
ALL STUDIES
Overall effects
All studies REM b) 19 0.200.05 0.35 2.60 ** 16.46 0
1 study excluded c) REM 18 0.230.08 0.39 2.92 ** 13.83 0
BDI d) REM 19 0.280.12 0.44 3.38 ** 19.87 9.40
Subgroup analyses
CBT in both formats Yes 11 0.15-0.07 0.38 1.32 10.15 1.46 n.s.
No 8 0.240.04 0.44 2.31 * 5.99 0
Recruitment Community 8 0.28-0.02 0.58 1.82 5.29 0 n.s.
Clinical 8 0.17-0.10 0.44 1.25 8.58 18.43
Other 3 0.18-0.10 0.45 1.27 2.23 10.37
Depressive disorder e) Yes 14 0.170.01 0.34 2.02 * 11.80 0 n.s.
No 5 0.34-0.02 0.71 1.84 o 3.95 0
Specific population f) Yes 4 0.20-0.04 0.44 1.62 2.70 0 n.s
No 15 0.200.01 0.39 2.03 * 13.77 0
Analyses Compl-only g) 12 0.290.06 0.51 2.51 * 9.31 0
ITT 5 0.08-0.16 0.32 0.67 4.39 8.95 n.s.
Effects at follow-up
1-3 months follow-up REM 7 0.05-0.21 0.32 0.38 7.89 23.99
6 months follow-up REM 7 -0.17-0.53 0.19 -0.92 9.89 39.31
STUDIES WITH AN EQUIVALENT INTERVENTION IN BOTH FORMATS
Overall effects
All studies REM 13 0.18-0.01 0.37 1.82 o 10.31 0
1 study excluded c) REM 12 0.230.03 0.42 1.22 * 7.83 0
BDI d) REM 13 0.270.05 0.48 2.38 * 14.69 18.30
Subgroup analyses
CBT in both formats Yes 11 0.15-0.07 0.38 1.32 10.15 1.46 n.s.
No 2 0.24-0.12 0.59 1.31 0.01 0
Recruitment Community 7 0.30-0.01 0.62 1.88 o 5.05 0 n.s.
Clinical 4 -0.09-0.41 0.24 -0.51 0.78 0
Other 2 0.31-0.03 0.65 1.79 o 0.79 0
Depressive disorder e) Yes 9 0.10-0.11 0.31 0.92 5.48 0 n.s.
No 4 0.460.05 0.87 2.18 * 2.54 0
Specific population f) Yes 1 0.24-0.14 0.37 1.25 0 0 n.s
No 12 0.15-0.07 0.37 1.37 10.16 0
Analyses Compl-only g) 9 0.20-0.06 0.46 1.53. 6.38 0 n.s.
ITT 4 0.11-0.23 0.45 0.64 4.11 27.01
Effects at follow-up
1-3 months follow-up REM 6 -0.04-0.39 0.31 -0.20 6.32 20.85
6 months follow-up REM 4 -0.23-0.89 0.43 -0.69 8.62 * 65.22
o: p < 0.1; *: p < 0.05; **: p < 0.01
a) only one of the Q-values was significant;
b) random-effects model;
c) Scott & Stradling, 1990;
d) effect sizes are exclusively based on the BDI;
e) a depressive disorder as established with a diagnostic interview;
f) women with postpartum depression; prison inmates; and multiple sclerosis patients;
g) completers-only versus intention-to-treat analyses.
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We calculated Orwin’s fail-safe N, which
is the number of studies with an effect size
of zero that should be found in order to
reduce the mean effect size from 0.20 to
0.10, and this was found to be 19.
When we excluded the study that was pos-
sibly included twice (study 1 by Scott and
Stradling)29, the results were almost the same
(d = 0.23; 95% CI: [0.08 0.39]; p < 0.05; I2 =
0). Because all the studies used the BDI as an
outcome measure, we also examined the dif-
ference between individual and group thera-
pies in which the effect size was calculated
on the basis of the BDI. Again the results
were very similar (d = 0.28; 95% CI: [0.12
0.44]; p < 0.01; I2 = 9.40). Visual inspection of
Figure 1, suggested that one of the compar-
isons from the study of Schmidt and col-
leagues16 my be an outlier. When we removed
this study from the analyses the results
remained almost the same (d = 0.17; 95% CI:
[0.02 0.33]; Z = 2.22, p < 0.05; I2 = 0).
We conducted separate analyses for the
twelve studies (thirteen comparisons) in
which equivalent interventions were examined
in the individual and in the group format. The
strength of the evidence is clearly stronger
when we limit the meta-analysis to the studies
in which an equivalent intervention was used
in both formats. We decided therefore to
repeat all analyses with this subgroup of stud-
ies. The results of these analyses are presented
in Table II. As can be seen in Table II, these
analyses resulted in comparable outcomes,
with an overall mean effect size of 0.18 (95%
CI: [-0.01 0.37]; Z = 1.82, p < 0.1; I2 = 0).
Figure 1. Standardized effect sizes indicating the difference in depressive symptoms between individual and group
therapies for depression at post-test.
Study name Statistics for cach study Std diff in means and 95% CI
Std diff Lower Upper Z-Value p-Value
in means limit limit
Subgroup analyses
We conducted some subgroup analyses
(Table II). First, we examined whether studies
in which cognitive behavioral interventions
were used in the individual and the group for-
mat differed significantly from studies in which
different manuals were used. As can be seen,
these two subgroups of studies did not differ
significantly from each other (p > 0.05). Then
we examined whether studies in which partici-
pants were recruited through the community
resulted in different mean effect sizes from
studies with clinical referrals. Again, no signif-
icant difference was found. We also examined
whether studies in which participants met diag-
nostic criteria for a depressive disorder differed
from studies in which other inclusion criteria
were used, and we compared studies in specif-
ic populations (women with postpartum
depression, prison inmates, and multiple scle-
rosis patients) to general adult populations.
Furthermore, we examined whether studies in
which completers-only analyses were conduct-
ed differed significantly from studies in which
intention-to-treat analyses were conducted. In
none of these analyses were significant differ-
ences between subpopulations found. As can
be seen from Table II, in most subgroups the
difference between individual and group treat-
ments was not significant.
Again, we repeated these analyses for the
twelve studies (thirteen comparisons) in
which an equivalent interventions were
examined in the individual and in the group
format (Table II). The results pointed in the
same directions as the subgroup analyses
with all studies. None of the subgroups dif-
fered significantly from other subgroups.
Metaregression analyses
We conducted a metaregression analysis
to examine whether the size of the groups in
the group treatments was related to the effect
sizes indicating the difference between indi-
vidual and group treatments. Because we
found that individual therapy was somewhat
more effective than group treatment, we con-
sidered it possible that the difference
between group and individual treatment
might decrease when the group size in the
group treatments was reduced. The group
size ranged from 5 to 13. However, a metare-
gression analysis did not indicate that the
effect size was related to the group size.
We also examined in a metaregression
analysis whether the BDI-score at pretest
was related to the effect size. A significant
result would indicate that the difference of
effects in group and individual treatments
would be more related to the severity of the
depression at pretest. However, these analy-
ses did not indicate either that pretest sever-
ity was related to the effect size.
When we limited the analyses to the stud-
ies in which equivalent interventions were
examined in the individual and in the group
format, both the group size and the BDI-
score at pretest were not significantly relat-
ed to the effect size.
Differences in drop-out from
interventions
Next, we examined whether group and
individual treatments resulted in different
drop-out rates from the interventions. We
could calculate these drop-out rates in eleven
studies (12 comparison groups). We found
that the drop-out rate was significantly lower
in individual interventions compared to group
interventions (OR = 0.56; 95% CI: [0.37 0.86];
p < 0.01), with very low heterogeneity (Q =
5.12, n.s.; I2 = 0). This difference remained
significant when we removed the study which
was possibly included twice (OR = 0.56; 95%
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CI: [0.36 0.87]; p < 0.05; Q = 5.11, n.s.; I2 =
0), and when we limited the analyses to the
studies in which equivalent interventions were
used in the individual and group formats (10
comparisons; OR = 0.55; 95% CI: [0.32 0.96];
p < 0.05; Q = 4.32, n.s.; I2 = 0).
Differences at follow-up
It was possible to compare the effects of
individual and group treatments at one to
three months after termination of the inter-
ventions in seven comparisons. The mean
effect size was not significant (d = 0.05; 95%
CI: [-0.21 0.32]), while heterogeneity was
still low (I2 = 23.99). At six months follow-
up, the difference between individual and
group treatments was not significant either
(seven comparisons, d = -0.17; 95% CI: [-0.53
0.19]), with low to moderate heterogeneity
(I2 = 39.31). No data were available for longer
follow-up periods. When we limited the
analyses to studies in which equivalent inter-
ventions were used in both formats, the
effects were comparable again (Table II).
Discussion
The results of meta-analyses indicate that
individual interventions may be more effec-
tive than group interventions in the treatment
of depression in  the short term. At one to six
months follow-up, no indications were
found that individual and group treatments
differed in effectiveness. The difference
between individual and group treatments,
however, was found to be small (d = 0.20). 
It is not clear whether such a difference is
clinically relevant. Because the costs of
group treatments are considerably lower
than the costs of individual therapy, it is not
clear whether the small difference in effects
is worth the costs. Because we also found
that the drop-out rate is significantly higher
in individual therapy, this may even strength-
en reduce the cost-effectiveness of group
therapies further. 
It has been estimated that the costs of
group therapy are about half of the costs of
individual therapy18. It should be possible to
develop a model in which these lower costs
were further examined, while including the
preferences of patients for each of the two
formats, the costs of the interventions, the
(possibly) larger effect of individual thera-
pies, and the higher drop-out in group thera-
pies. It should be possible to conduct a mod-
eling study, which would results in a
comparison of individual and group thera-
pies in terms of quality of life and economic
costs. Such a study is, however, complex
and can not be conducted within the context
of the current study.
However, the results of our study should
be interpreted very cautiously because of
the small number of studies, and should at
this stage not discourage the development of
group treatments, without adequately test-
ing the topic with a more reasonable num-
ber of studies.
No indications were found that the differ-
ence between group and individual treat-
ments were related to the characteristics of
the groups, interventions or studies we
examined. Apparently, this difference exists
regardless of these characteristics. However,
the number of studies in each subgroup is
very small and it can not be concluded,
therefore, that the subgroup factors are not
significant. The fact that we did not find a
relationship may be related to the small
number of studies in the subgroups.
We also found that the drop-out rate is
smaller in individual treatments compared
to the drop-out rate in group treatments. It
seems that the cohesion between group
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members and the relationship between the
patient and the group leader, is not as strong
as the personal relation between the patient
and his or her individual therapist. Or it may
be possible that unpleasant interpersonal
events in the group may induce some partic-
ipants to drop out. This should be the sub-
ject for future research, and this finding
should also be interpreted very cautiously
because of the small number of studies and
the low quality of included studies. 
This study has several limitations. The
first important limitation of this meta-analy-
sis is, as indicated earlier, that we were only
able to include a relatively small number of
studies, and several of these had very small
sample sizes. This small number of studies
and participants is especially important,
because we did not compare treatments to
control conditions, but to each other. In
these analyses, small differences should be
expected and in order to find small differ-
ences, large numbers are needed. Particular-
ly with regard to the longer term, insuffi-
cient studies were available to assess the
difference between the two types of treat-
ments. A second limitation is that the quali-
ty of most included studies was not optimal.
Although it is clearly inherent in studies of
psychological treatments that it is not possi-
ble to conceal to participants to which con-
dition they are assigned (in waiting list con-
trol conditions it is not possible at all), many
studies did not meet other major quality cri-
teria, such as assignment to conditions by an
independent person, and blinding of asses-
sors. Most studies only conducted com-
pleters-only analyses instead of intention-
to-treat-analyses.
Despite these limitations, our results indi-
cate that individual treatments may be more
effective than group treatments. It can easily
be an artefact caused by the low quality of
the included studies. If this difference is an
actual difference, it is not clear what causes
this difference. Do individual and group
treatments work through different mecha-
nisms, resulting in different effect sizes? Or
do they work through the same mecha-
nisms, but are some of these mechanisms
limited (in some patients) through the group
processes? There is no clear answer to this
question yet. It is estimated that psychother-
apies work through placebo effects (15%),
extratherapeutic change (40%), common
factors of psychotherapy (30%), and the
techniques of the treatment (15%)34,35. There
is no direct reason to assume that placebo
effects and extratherapeutic change work
differently in group and individual treat-
ments. Most studies in our meta-analysis
used the same manuals and protocols in the
individual and group formats, and one may
expect that the actual techniques in these
studies are comparable in both formats. It
seems less plausible therefore that the dif-
ferences in effects of the two formats are
caused by the differences in techniques. So,
differences between the two formats are
probably caused by differences in the com-
mon factors. Important common factors
include person-centered facilitative condi-
tions (empathy, warmth, congruence) and
the therapeutic alliance34. In group treat-
ments group cohesion may play a role in
realizing effects of an intervention, while
individual therapies may strengthen the
therapeutic relation between client and ther-
apist more than in group therapies. More
research is needed to examine these com-
mon factors in both formats.
However, it is also very well possible that
individual and group therapies work
through comparable mechanisms, but that
the group format is limiting these therapeuti-
cal mechanisms. For example, it has suggest-
ed that there are multiple memories involving
the self that compete to be retrieved, and that
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therapies produces changes in the relative
activation of positive and negative represen-
tations such that the positive ones are assist-
ed to win the retrieval competition36. This
would mean that therapies may differ from
each other considerably, but still realize
comparable effects, as long as they succeed
in breaking the dominance of negative rep-
resentations. This would suggest that indi-
vidual therapies are more successful in this
process than group therapies.  
This meta-analysis found indications that
individual therapies may be more effective
than group therapies at the short-term. How-
ever, the number of studies, the limited
quality of included studies, the uncertainty
about the difference at the longer term and
about the clinical relevance of this finding,
should at this stage not discourage the
development of group treatments. More
research is needed to examine the exact
mechanisms of change in individual and
group treatments, before definite conclu-
sions can be drawn.
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